Welcome to our dedicated page for Evogene Ltd. news (Ticker: $EVGN), a resource for investors and traders seeking the latest updates and insights on Evogene Ltd. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Evogene Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Evogene Ltd.'s position in the market.
Rhea-AI Summary
Casterra Ag Ltd. (EVGN) announces the appointment of Mr. Yoash Zohar as the new CEO to lead the company's operational expansion, with a focus on increasing castor seed production capacity to support the bio-diesel industry's growing needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.93%
Tags
-
Rhea-AI Summary
Lavie Bio Ltd. (EVGN) announces an exclusive distribution agreement with WinField United Canada for its bio-inoculant seed treatment Yalos™, targeting spring wheat, durum, and barley crops in Canada. The partnership supports Lavie Bio's 2024 sales growth plan and aims to offer a 4:1 return on investment for farmers, given current market values.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.07%
Tags
-
Rhea-AI Summary
Lavie Bio Ltd. (EVGN) to Expand Yalos™ Product Line to Include Durum and Barley, Achieving 8.3% and 6.6% Production Improvement Respectively in Field Trials, Exceeding Industry Standards
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
Rhea-AI Summary
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) Announces Q3 2023 Financial Results and Conference Call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
-
Rhea-AI Summary
EVGN: Lavie Bio's LAV321 Bio-Fungicide Shows Promising Results in 2023 Field Trials, Protecting Against Downy Mildew and Late Blight Diseases
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
-
Rhea-AI Summary
Evogene Ltd. will release its financial results for Q3 2023 on November 15, 2023. The company aims to revolutionize life-science product discovery and development. A conference call will be held on the same day at 9:00 AM ET to discuss the results. The call can be joined using the provided numbers. A replay of the call will be available for three days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.88%
Tags
Rhea-AI Summary
Colors Farm, Evogene, and Ben-Gurion University have announced a collaboration to develop gene editing technology for crustaceans. The project aims to enhance traits such as growth rate, disease resistance, and environmental adaptation in giant freshwater prawn, white leg shrimp, and red swamp crayfish. The initiative has received a grant from the Israel Innovation Authority. The global shrimp market is predicted to reach US$88 billion by 2028 with a CAGR of 4.7%, while the crayfish market is expected to grow at a CAGR of 31.5% from 2024-2032. This collaboration aims to meet the rising demand for seafood and sustainable aquaculture practices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
-
Rhea-AI Summary
Evogene provides an update to investors and stakeholders amidst the ongoing security situation in Israel.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.55%
Tags
-
Rhea-AI Summary
Casterra Ag Ltd. has announced the shipment of its first batch of high-yield, high-oil castor seeds valued at US$1 million. This is part of a framework agreement with a world-leading oil and gas company, with US$11.3M purchase orders. The seeds have a germination percentage rate of 90%, exceeding industry standards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
Rhea-AI Summary
Evogene Ltd. announces financial results for Q2 2023, highlighting achievements and partnerships. Evogene secures $8.5M investment, receives purchase orders worth $11.3M, and closes $20M financing round for Biomica. Lavie Bio enters licensing agreement with Corteva for $5M upfront payment. AgPlenus appoints Dr. Adrian Percy to board of directors. Evogene reports consolidated cash of $33.9M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.23%
Tags
Evogene Ltd.
Nasdaq:EVGN
EVGN Rankings
EVGN Stock Data
33.38M
46.63M
1.66%
8.91%
0.17%
Pesticide and Other Agricultural Chemical Manufacturing
Manufacturing
United States of America
Rehovot
About EVGN
evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch